Navigation Links
Baron & Budd Supports Encouraging New Development in Mesothelioma Treatment
Date:11/15/2013

LOS ANGELES (PRWEB) November 15, 2013

Mesothelioma survival rates may be substantially improved through increased use of a certain form of chemotherapy, researchers at the Moffit Cancer Center and Research Institute at the University of South Florida recently announced. Patients undergoing this repeated treatment, according to the researchers, not only live longer but also have a better quality of life.

The announcement was the result of a lengthy study of peritoneal mesothelioma patients between June of 2004 and March of 2012. Researchers reported that those who underwent a second treatment of heated intraperitoneal chemotherapy, or HIPEC, survived more than three times longer than those who had only one round. The findings were recently published in the Annals of Surgical Oncology.
(http://www.annsurgoncol.org/journals/abstract.html?v=0&j=10434&i=0&a=3341_10.1245_s10434-013-3341-7&doi=)

The HIPEC procedure is performed as soon as possible after a surgery in order to reduce the number of tumor cells in a patient. After a tumor has been removed, a solution containing various chemotherapeutic agents is heated to 106 degrees Fahrenheit. This solution is circulated through a patient’s abdominal cavity at a very precise rate for two hours. The treatment has been proven effective at reducing patient discomfort and killing the cancerous cells.

“We are continually encouraged by the commitment and excellence of the bright minds that are working to fight this terrible disease,” said Russell Budd, managing director of mesothelioma law firm Baron & Budd. “We applaud the work of the Moffit Cancer Center researchers, as well as all that of the other professionals who tirelessly work for a cure.”

If you would like to learn
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
4. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
5. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
6. Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
7. Baron and Budd Announces Second Transvaginal Mesh Lawsuit Settlement for Bard
8. Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
9. Mesothelioma Law Firm Baron & Budd Calls Attention to Veterans Suffering from Asbestos-Related Diseases
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , SOUTH SAN FRANCISCO, Calif., July 10 ... the International Society on Thrombosis and Haemostasis (ISTH) XII ... drug elinogrel, a P2Y(12) ADP receptor antagonist currently in ... inhibitor anticoagulant antidote in pre-clinical development, as well as ...
... adulthood, study shows , THURSDAY, July 9 (HealthDay News) ... can persist into adulthood, U.S. researchers report. , Young ... than 5.5 pounds at birth) have an increased risk ... findings suggest that not only are [low birth weight] ...
... ... are now available in Canada from Electro Sonic. , ... Chatsworth, CA (PRWEB) July 10, 2009 -- NMB Technologies Corporation, a ... have reached a distribution agreement. Under the terms of this agreement, Electro Sonic, ...
... 10 Eli Lilly and Company (NYSE: ... 35th year of support for the Indiana Black Expo (IBE) Summer Celebration, ... presence at the IN Shape Indiana Black and Minority ... in these uncertain economic times. , , An example of this ...
... Growing in the number of those afflicted, Alzheimer,s takes ... caregivers, "Alzheimer,s Days Gone By: For Those Caring For Their ... Lueckenotte weaves a heartfelt mix of personal experience and sound ... of loved ones during the descent into dementia. , ...
... (Nasdaq: QGLY ) , ... Rosenbloom has resumed providing services to the Company,s Quigley Pharma subsidiary. ... late May, 2009. , , Ted Karkus, Chairman and interim ... Rosenbloom again serving our Pharma subsidiary and helping in the development ...
Cached Medicine News:Health News:Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 2Health News:Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 3Health News:Respiratory Issues Linger for Smallest Babies 2Health News:NMB Expands in Canada 2Health News:Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo 2Health News:Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo 3Health News:Insightful Handbook for Alzheimer's Caregivers 2Health News:Insightful Handbook for Alzheimer's Caregivers 3Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 2Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 3
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 ... plc (NASDAQ: ENDP ) (TSX: ENL), and ... announced today that they have submitted a New Drug ... U.S. Food and Drug Administration (FDA).  Buprenorphine HCl Buccal ... severe enough to require daily, around-the-clock, long-term opioid treatment ...
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) has ... Glucose Market" report to their offering. ... insight focuses on the developments in the self-monitoring blood ... . Reimbursement analysis and the effects of competitive bidding ... 73 SMBG meters have been performed, based on the ...
(Date:12/22/2014)... and STOCKHOLM , Dec. ... (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced that ... of the European Medicines Agency (EMA) has adopted a ... histolyticum) for the treatment of adult men with Peyronie,s ... at least 30 degrees at the start of therapy. ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... 2007 /PRNewswire/ -- Mersana, a,cancer therapeutics company, announced ... product candidate, XMT-1001, will,be presented in two posters ... of Cancer Research (AACR) taking place April,14-18th in ... can be,viewed online at the AACR website at ...
... 13, 2007 - Biogen Idec Inc.,(NASDAQ: BIIB) ... the,Academy of Managed Care Pharmacy's (AMCP) 2007 ... a cost-effective therapy in,multiple sclerosis (MS) when ... comprehensive analysis of medical and pharmacy,costs, the ...
Cached Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 3
These flexible stone retrieval devices are reusable, 3 Fr in diameter, with a working length of either 60 cm or 115 cm...
... The Brasseler USA™ MicroLine™ Small Bone ... of operation while performing under the ... powered system developed for small bone ... Drill, Sagittal Saw (Extended Length Available), ...
... Drill, with hand throttle, 30,000 ... Built-in medium bur guard included, ... bur guards are also available. ... hand throttle (#1940) for use ...
... Electric Micro Drill, without hand ... of torque. Built-in medium bur ... extra-long (#1100-006) bur guards are ... with foot throttle (#6401-000), can ...
Medicine Products: